What is the difference between batch traceability and individual packaging verification?

Batch traceability helps to find its quantities and execute the recall. Authentication verification of individual packaging of a drug has another purpose and relies on an identifier and verification process for it. These actions must be coordinated, but do not replace each other.

How is product recall to work?

Once a reliable recall signal is received, the system must identify the affected batches and locations, stop the authorized sale where necessary, create clear tasks, and save who and when executed them.

Which indicator best shows the quality of the process of batches and recalls?

The time between the receipt of the recall and the identification and confirmation of control of the affected balance.The proportion of write-offs that could be reduced by earlier redistribution or other management of the balance is also important for the validity process.

Is the balance-locking system alone sufficient to complete the cancellation?

No. It must be confirmed that the affected goods are physically separated and arranged according to the recall order. Non-compliant quantities must remain open for investigation. The electronic status of the task does not replace the actual inspection.

Pharmacy batch and recall management system

The pharmacy worker sees the stocks, validity and sales restrictions of the batches. In case of recall, goods can be found and tasks for their detention can be assigned.

batch acceptance, balance, sale, validity and recall actions are not easily linked up to specific location or lawful customer information. A lot of work is done by hand at the time of recall, and write-offs and safety risks increase.

How the solution works

The product, batch and validity data recorded at the time of admission are linked to the actual balance.
Upon receipt of the recall notice, the employee in charge confirms the affected goods and control actions.
Pharmacies receive tasks to stop sales, physically separate goods and check quantity.
Completion shall be confirmed by a reconciliation of quantities and outstanding exceptions; the procedures applied shall be communicated.

Key challenges

Control of lots, validity and recalls too slow

Solution capabilities

batch Road to the Pharmacy

The responsible employee may determine where a particular batch is accepted and where its balance should be, according to the movements actually registered.

Control of Validity

The pharmacy receives action in time for those goods for which the balance-to-validity ratio requires verification or allowable redistribution.

Execution of the revocation

Clear instruction is transmitted to each affected area, and completion is confirmed by the amount and action checked.

Basis for information

Only reliably linked data and the way allowed for a specific action are used to inform. In the absence of a batch-to-buyer relationship, all affected buyers cannot be said to have been identified.

Business context

Control of lots, validity and recalls too slow: batch acceptance, balance, sale, validity and recall actions are not easily linked up to specific location or lawful customer information. A lot of work is done by hand at the time of recall, and write-offs and safety risks increase.
Withdrawal actions reach specific stocks: For customer trust, it is important that the wrong or cancelled batch is not further proposed. Its visible path and detention tasks allow coordination of actions across the network. Employees have a clearer basis for answering a question about a specific item.

Core features

batch Road to the Pharmacy
Control of Validity
Execution of the revocation
Basis for information

Key integrations

ERP / Commodity Accounting: Acceptance of goods, batches, term of validity and movement of the balance.
WMS / Network Stock System: batch location, warehouse and pharmacy remnants and transfers.
Reliable source of cancellations: recall identifier, affected batch and mandatory action information.
Pharmacy POS and workspace: The result of a sale blocking or other mandatory control action.

Potential impact (%)

The ranges indicate an illustrative relative change in the metric under the stated assumptions. Results depend on the starting position and actual use of the solution. Percentages for different metrics must not be added together.

Time between receipt of the recall and confirmation of identification and control of the affected stock

6–25%Decreasing

This illustrative scenario assumes that 20-50% of waiting caused by missing information or unclear responsibility can be addressed. That share is assumed to fall by 30-50%. Company data is needed to verify both the addressable share and the resulting change.

Measure the time between receiving a reliable recall message and confirming the control status of all affected locations.

Share of write-offs in selected categories

2–12%Decreasing

This illustrative scenario assumes that 10-30% of the metric is attributable to addressable planning and execution shortcomings. That share is assumed to fall by 20-40%. Company data is needed to verify both the addressable share and the resulting change.

The portion of the written-down quantity or value due to the expiration date before and after the process change for the same set of categories. The percentage is calculated on the amount of production cost sold and written off in the same category.

Conditional calculation scenarios. The assumptions have not been validated against client measurements.

When this solution is relevant

batch acceptance, balance, sale, validity and recall actions are not easily linked up to specific location or lawful customer information
During the recall, much work is done by hand, and write-offs and safety risks increase

Implementation requirements

The traceability of medicines is checked by the details of reception, movement and stock. The recall procedure must define the determination of affected quantities, physical separation and the investigation of discrepancies, and the allocation of tasks is based on these responsibilities.